COVID-19

Adverse events included self-limited nausea and diarrhea with no difference between the 2 groups.

While navigating the COVID-19 crisis, organizations should review their game plan for future emergencies.

Primary care will require a focus on individual and community health in the post coronavirus disease 2019 (COVID-19) era, according to a session presented on Thursday during the Pharmacy Quality Alliance (PQA) 2020 Annual Meeting.

The results will help the rare disease community shed light on the needs of people with rare diseases during the COVID-19 pandemic and other potential health crises, in addition to informing future research efforts.

The study aims to perform a medication risk stratification using drug claims data and to simulate the impact of the addition of various repurposed drugs on medication risk shortages in elderly people.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Staying up-to-date on immunizations is crucial to prevent outbreaks of vaccine-preventable diseases.

The impact of COVID-19 on pharmacy has been significant in the short-term, and recent developments have shown that there is opportunity for that to translate into long-term changes for the industry.

With the outbreak of COVID-19, pharmacists throughout the world are called not just to dispense medications but also, importantly, to be a source of critical information and support for the public.

Pharmacy Quality Solutions Annual Trend Report focuses on questions around consumer perceptions and behaviors.

The impact of COVID-19 on the health plan enterprise appears to be practical and functional rather than strategic and financial.

Sandra Leal, PharmD, MPH, FAPhA, CDE, executive vice president, Health Plans and Payers Division of Tabula Rasa Healthcare and president-elect of American Pharmacist Association, discusses value-based care and changing payment models.

Researchers at Northwestern University have discovered a strong connection between severe vitamin D deficiency and mortality rates after studying global data from the coronavirus disease 2019 (COVID-19) pandemic.

A new report from PrEP4All Collaboration warned that current research efforts aimed at controlling the COVID-19 pandemic are missing an important area of research into PrEP.

42.8% of medical staff treating patients with COVID-19 experienced serious skin injuries from the use of personal protective equipment.

A retrospective study has found that well-controlled blood glucose was associated with improved outcomes among COVID-19 patients.

Governor Gavin Newsom granted California’s 47,000 pharmacists the ability to order and administer coronavirus disease 2019 (COVID-19) tests throughout the state.

More than one-third of Americans report that COVID-19 has had a serious impact on their mental health.

PPE and appropriate infection control training are vital to keep health care workers safe, according to the researchers from Oregon Health and Science University.

Over the past 5 years, pharmacy residency positions have increased by 46% nationwide.

According to a study, men have higher concentrations of ACE2 in their blood than women, which may be a potential explanation for why men are more susceptible to COVID-19.

Leronlimab has been granted 2 other Fast Track designations as a combination therapy with HAART for HIV and as a treatment for metastatic triple-negative breast cancer.

The study was launched in response to an earlier joint statement issued by the AHA, the ACC, and the Heart Failure Society of America, which urged more research on the subject.

Independent community pharmacy owners in New York City discuss what it’s like to operate a pharmacy and support patients in one of the largest coronavirus disease 2019 (COVID-19) hot spots in the country.

Patients with the coronavirus disease 2019 (COVID-19) are filling more than half of the ICU beds in 40% of the hospitals represented in the survey.

The new order took effect immediately, on May 7, according to the Connecticut Pharmacists Association.

According to a new study, even the sickest patients with COVID-19 who require ventilators in ICUs improve when given treatment that follows existing guidelines for respiratory failure.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

FDA recently released new temporary guidelines on non-standard PPE practices for sterile compounding by pharmacy compounders during the COVID-19 pandemic.

Clinicians are becoming increasingly concerned about evidence that COVID-19 could also be a thromboembolic disease.